Munich, Germany

Alfred Muller

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alfred Muller. Retrieved from https://idiyas.com/inventor/alfred-muller-kcec33os

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alfred Muller - Innovator in Antibiotic Preparations

Introduction

Alfred Muller is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic preparations. His work has had a lasting impact on medical treatments and patient care.

Latest Patents

Alfred Muller holds a patent for "High dosage orally administrable cephalosporin antibiotic preparations." This patent describes high-dosage, orally administrable antibiotic preparations containing an antibiotic agent of the cephalosporin type, along with 5 to 15% of a mixture of auxiliary agents, and outlines the process for preparing them. This innovation is crucial for enhancing the effectiveness of antibiotic treatments.

Career Highlights

Alfred Muller is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to focus on developing advanced antibiotic solutions that address various health challenges.

Collaborations

Throughout his career, Alfred Muller has collaborated with esteemed colleagues such as Werner Fulberth and Dietrich Hiller. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alfred Muller is a distinguished inventor whose work in antibiotic preparations has made a significant impact on the pharmaceutical industry. His contributions continue to influence medical practices and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…